PROCTER & GAMBLE HEALTH | LINCOLN PHAR | PROCTER & GAMBLE HEALTH/ LINCOLN PHAR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 13.7 | 252.2% | View Chart |
P/BV | x | 10.6 | 2.4 | 443.0% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 801.3% |
PROCTER & GAMBLE HEALTH LINCOLN PHAR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
LINCOLN PHAR Mar-23 |
PROCTER & GAMBLE HEALTH/ LINCOLN PHAR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 380 | 1,412.4% | |
Low | Rs | 3,883 | 255 | 1,522.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 254.8 | 290.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 36.4 | 379.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 41.0 | 378.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.50 | 6,333.3% | |
Avg Dividend yield | % | 2.1 | 0.5 | 434.8% | |
Book value per share (Unadj.) | Rs | 447.6 | 250.9 | 178.4% | |
Shares outstanding (eoy) | m | 16.60 | 20.03 | 82.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.2 | 501.0% | |
Avg P/E ratio | x | 33.5 | 8.7 | 383.5% | |
P/CF ratio (eoy) | x | 29.8 | 7.7 | 384.6% | |
Price / Book Value ratio | x | 10.3 | 1.3 | 816.4% | |
Dividend payout | % | 68.7 | 4.1 | 1,667.4% | |
Avg Mkt Cap | Rs m | 76,761 | 6,358 | 1,207.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 932 | 221.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 5,103 | 241.0% | |
Other income | Rs m | 184 | 225 | 81.8% | |
Total revenues | Rs m | 12,480 | 5,328 | 234.2% | |
Gross profit | Rs m | 3,247 | 892 | 364.0% | |
Depreciation | Rs m | 281 | 92 | 306.6% | |
Interest | Rs m | 8 | 20 | 37.9% | |
Profit before tax | Rs m | 3,142 | 1,005 | 312.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 276 | 307.2% | |
Profit after tax | Rs m | 2,295 | 729 | 314.8% | |
Gross profit margin | % | 26.4 | 17.5 | 151.1% | |
Effective tax rate | % | 27.0 | 27.4 | 98.2% | |
Net profit margin | % | 18.7 | 14.3 | 130.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,911 | 299.5% | |
Current liabilities | Rs m | 6,791 | 962 | 706.3% | |
Net working cap to sales | % | 40.0 | 57.8 | 69.3% | |
Current ratio | x | 1.7 | 4.1 | 42.4% | |
Inventory Days | Days | 263 | 128 | 204.7% | |
Debtors Days | Days | 343 | 975 | 35.2% | |
Net fixed assets | Rs m | 10,617 | 2,454 | 432.6% | |
Share capital | Rs m | 166 | 200 | 82.9% | |
"Free" reserves | Rs m | 7,265 | 4,824 | 150.6% | |
Net worth | Rs m | 7,431 | 5,025 | 147.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 6,365 | 350.8% | |
Interest coverage | x | 409.1 | 50.5 | 810.0% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.8 | 68.7% | |
Return on assets | % | 10.3 | 11.8 | 87.6% | |
Return on equity | % | 30.9 | 14.5 | 212.9% | |
Return on capital | % | 42.4 | 20.4 | 207.8% | |
Exports to sales | % | 0 | 57.4 | 0.0% | |
Imports to sales | % | 13.1 | 2.0 | 665.0% | |
Exports (fob) | Rs m | NA | 2,931 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 100 | 1,602.5% | |
Fx inflow | Rs m | 1,465 | 2,931 | 50.0% | |
Fx outflow | Rs m | 1,605 | 100 | 1,602.5% | |
Net fx | Rs m | -140 | 2,831 | -5.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 393 | 601.1% | |
From Investments | Rs m | -215 | -366 | 58.7% | |
From Financial Activity | Rs m | -985 | -45 | 2,187.7% | |
Net Cashflow | Rs m | 1,160 | -19 | -6,165.2% |
Indian Promoters | % | 0.0 | 49.5 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 4.0 | 501.8% | |
FIIs | % | 6.2 | 3.9 | 158.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 50.5 | 95.5% | |
Shareholders | 56,778 | 31,375 | 181.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | LINCOLN PHAR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.11% | 0.45% |
1-Month | -1.15% | -1.63% | 2.55% |
1-Year | 0.73% | 52.96% | 56.14% |
3-Year CAGR | -8.76% | 32.07% | 15.22% |
5-Year CAGR | 4.97% | 26.07% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the LINCOLN PHAR share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of LINCOLN PHAR the stake stands at 49.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of LINCOLN PHAR.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
LINCOLN PHAR paid Rs 1.5, and its dividend payout ratio stood at 4.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of LINCOLN PHAR.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.